BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharma S, Agarwal S, Gunjan D, Kaushal K, Anand A, Mohta S, Shalimar, Saraya A. Long-term Outcomes with Carvedilol versus Propranolol in Patients with Index Variceal Bleed: 6-year Follow-up Study. J Clin Exp Hepatol 2021;11:343-53. [PMID: 33994717 DOI: 10.1016/j.jceh.2020.08.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Mariadi IK, Daniella D, Paulus IB, Somayana G, Sindhughosa DA. Carvedilol as Primary and Secondary Prophylaxis to Prevent Variceal Hemorrhage in Patients With Hepatic Cirrhosis: a Systematic Review and Meta-analysis.. [DOI: 10.21203/rs.3.rs-2426644/v1] [Reference Citation Analysis]
2 Gananandan K, Mookerjee R, Jalan R. Use of Non-selective Beta blockers in Decompensated Cirrhosis and ACLF. Curr Hepatology Rep 2022;21:29-36. [DOI: 10.1007/s11901-022-00584-2] [Reference Citation Analysis]
3 Dunne PDJ, Young D, Chuah CS, Hayes PC, Tripathi D, Leithead J, Smith LA, Gaya DR, Forrest E, Stanley AJ. Carvedilol versus endoscopic band ligation for secondary prophylaxis of variceal bleeding-long-term follow-up of a randomised control trial. Aliment Pharmacol Ther 2022;55:1581-7. [PMID: 35322892 DOI: 10.1111/apt.16901] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Premkumar M, Anand AC. Overview of Complications in Cirrhosis. J Clin Exp Hepatol 2022;12:1150-74. [PMID: 35814522 DOI: 10.1016/j.jceh.2022.04.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]